Celleron has established a unique partnership with Oxford University Hospitals NHS Trust to facilitate its clinical trial programme.

Celleron and AstraZeneca entered into an exclusive world-wide licensing partnership to develop CXD101

Celleron and Nuance Biotech secured a partnership to develop Celleron’s clinical assets in Greater China and South Africa